Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Simmonds

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 30, 2024
Measurement of treatment burden in cystic fibrosis: A systematic reviewRana Altabee, Martin J Mwamba, David Turner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 17, 2020
The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasisLeah Cuthbertson, Imogen Felton, Phillip James, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2019
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphismBente L Aalbers, Yasmin Yaakov, Nico Derichs, et al.
Trials|August 29, 2021
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measuresSilke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, et al.
The European Respiratory Journal|April 2, 2013
A molecular comparison of microbial communities in bronchiectasis and cystic fibrosisRachael M Duff, Nicholas J Simmonds, Jane C Davies, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 21, 2019
Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung functionMarcello Di Paolo, Elisabetta Teopompi, Daniela Savi, et al.
Chest|February 14, 2014
Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung diseasePeter J Barry, Barry J Plant, Arjun Nair, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samplesDominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
BMJ Open Quality|April 15, 2025
Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement projectJamie Cheong, Shereen Boreland, Elaine Shattock, et al.
Thorax|September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluationIdan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 30, 2024
Measurement of treatment burden in cystic fibrosis: A systematic reviewRana Altabee, Martin J Mwamba, David Turner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 17, 2020
The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasisLeah Cuthbertson, Imogen Felton, Phillip James, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2019
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphismBente L Aalbers, Yasmin Yaakov, Nico Derichs, et al.
Trials|August 29, 2021
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measuresSilke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, et al.
The European Respiratory Journal|April 2, 2013
A molecular comparison of microbial communities in bronchiectasis and cystic fibrosisRachael M Duff, Nicholas J Simmonds, Jane C Davies, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 21, 2019
Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung functionMarcello Di Paolo, Elisabetta Teopompi, Daniela Savi, et al.
Chest|February 14, 2014
Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung diseasePeter J Barry, Barry J Plant, Arjun Nair, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samplesDominic A Hughes, Mark Rosenthal, Leah Cuthbertson, et al.
BMJ Open Quality|April 15, 2025
Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement projectJamie Cheong, Shereen Boreland, Elaine Shattock, et al.
Thorax|September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluationIdan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Pageof 7